Invention Grant
- Patent Title: Heteroaryl compounds as P2Y1 receptor inhibitors
- Patent Title (中): 杂芳基化合物作为P2Y1受体抑制剂
-
Application No.: US12619702Application Date: 2009-11-17
-
Publication No.: US08273772B2Publication Date: 2012-09-25
- Inventor: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y. S. Lam
- Applicant: James C. Sutton , Zulan Pi , Rejean Ruel , Alexandre L'Heureux , Carl Thibeault , Patrick Y. S. Lam
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Jing G. Sun
- Main IPC: A61K31/4436
- IPC: A61K31/4436 ; C07D417/12
Abstract:
The present invention provides novel heteroaryl compounds and analogues thereof, which are selective inhibitors of the human P2Y1 receptor. The invention also provides for various pharmaceutical compositions of the same and methods for treating diseases responsive to modulation of P2Y1 receptor activity.
Public/Granted literature
- US20100093689A1 HETEROARYL COMPOUNDS AS P2Y1 RECEPTOR INHIBITORS Public/Granted day:2010-04-15
Information query
IPC分类:
